Orbia Advance Corporation SAB de CV
Orbia's capital structure is characterized by a high debt-to-equity ratio of 2.67, indicating significant leverage. The company's liquidity position is moderate, with a current ratio of 1.52, but its free cash flow is negative at -115 million USD, which may constrain its ability to fund operations without external financing. The company's return on equity is -21.41%, and its return on assets is -4.13%, both of which are below typical performance metrics for the industry. In terms of profitability, Orbia's net income is negative at -457 million USD, and its operating income is 370 million USD, which is lower than the industry median for commodity chemicals. The company's gross profit of 1.626 billion USD suggests some level of cost control, but the overall profitability is weak. The company's operating cash flow is 840 million USD, which is a positive sign, but it is not sufficient to cover capital expenditures of 405 million USD. Orbia's revenue is concentrated in the chemicals segment, with no disclosed geographic breakdown. The company's exposure to a single business line may increase its vulnerability to market fluctuations in the chemicals industry. The company's growth trajectory is uncertain, with no specific revenue growth projections provided. However, the company's capital expenditures suggest ongoing investment in its operations. The company faces several risk factors, including a high debt-to-equity ratio and negative free cash flow, which could lead to liquidity constraints. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag. There are no recent events or filings that significantly impact the company's risk profile. Analyst estimates for Orbia are mixed, with a mean price target of 26.33 USD and a median price target of 25.00 USD. The mean recommendation is 2.50, indicating a slight bias towards a hold or buy rating. There is one strong-buy recommendation, six buy recommendations, and six hold recommendations.
Business. Orbia Advance Corporation SAB de CV is a chemicals company that produces commodity chemicals and generates revenue primarily through the sale of chemical products.
Classification. Orbia is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.
- Orbia has a high debt-to-equity ratio of 2.67, indicating significant leverage.
- The company's net income is negative at -457 million USD, and its operating income is 370 million USD, which is lower than the industry median for commodity chemicals.
- Orbia's liquidity position is moderate, with a current ratio of 1.52, but its free cash flow is negative at -115 million USD.
- The company's return on equity is -21.41%, and its return on assets is -4.13%, both of which are below typical performance metrics for the industry.
- Analyst estimates for Orbia are mixed, with a mean price target of 26.33 USD and a median price target of 25.00 USD.
- # RATIONALES
- {
- "margin_outlook_rationale": "The company's gross profit margin is 21.33%, but the net margin is negative at -6.00%, indicating significant cost pressures and operational inefficiencies.",
- Net cash is negative after subtracting total debt.